Alimera Sciences, Inc. (ALIM)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
1.49-0.06 (-3.87%)
At close: 4:00 PM EDT
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close1.55
Bid1.42 x 100
Ask1.61 x 400
Day's Range1.44 - 1.58
52wk Range1.01 - 5.15
1y Target EstN/A
Market Cap94.43M
P/E Ratio (ttm)-2.20
Avg Vol (3m)904,293
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Capital Cube9 days ago

    ETF’s with exposure to Alimera Sciences, Inc. : September 20, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to Alimera Sciences, Inc. Here are 5 ETF’s with the largest exposure to ALIM-US. Comparing the performance and risk of Alimera Sciences, Inc. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • GlobeNewswire23 days ago

    Alimera Sciences Announces 23 Clinical Presentations and a Sponsored Symposium at 16th EURETINA Congress

    ATLANTA, Sept. 06, 2016-- Alimera Sciences, Inc., a leader in research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that data from an unprecedented 23 ...

  • Alimera Sciences Inc (ALIM): Great Point Partners Reveals 5.12% Stake
    Insider Monkeylast month

    Alimera Sciences Inc (ALIM): Great Point Partners Reveals 5.12% Stake

    Jeffrey Jay and David Kroin‘s Great Point Partners reported the acquisition of 3.25 million common shares of Alimera Sciences Inc (NASDAQ:ALIM) which account for 5.12% of the company’s outstanding stock, via a recent 13G filing with the SEC. The acquisition represents a new addition to Great Point Partners’ portfolio. Alimera Sciences is a pharmaceutical company that works […]